Journal of Obesity & Metabolic Syndrome· 2026Q1· Review
Relationship between Vitamin D Status and the Risk of Obesity without Diagnosed Metabolic Syndrome: A Meta-Analysis of Observational Studies
- 0citations
- Q1SCImago
- 2026year
Short summary
Lower vitamin D (VD) levels are associated with a higher risk of healthy obesity, with serum/plasma 25-hydroxyvitamin D concentrations negatively correlating with this risk (mean difference = -3.98).
AI-generated from the title and abstract; the full text is not read.
Key points
- Lower serum/plasma 25-hydroxyvitamin D concentrations are negatively associated with the risk of healthy obesity (mean difference = -3.98).
- Obese individuals showed a higher prevalence of VD deficiency compared to controls (OR = 2.02).
- VD insufficiency was positively associated with obesity risk (OR = 1.17).
- Differences in findings across subgroups were influenced by VD detection methods and assessment criteria.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background: The association between daily vitamin D (VD) intake and the risk of healthy obesity remains controversial. Methods: PubMed, Embase, Web of Science, Wanfang Database, China Science and Technology Periodical Database, and the Cochrane Database of Systematic Reviews were systematically searched for published observational studies up to January 2025. Ultimately, 74 studies were included, and pooled estimates were obtained using RevMan version 5.3. Subgroup analyses were conducted by age, VD detection method and assessment criteria, and obesity grade. Results: Among 5,283 articles identified, 74 studies with 110,838 individuals met the inclusion criteria. Serum/plasma 25-hydroxyvitamin D concentrations were negatively associated with the risk of healthy obesity (mean difference=-3.98; 95% confidence interval [CI], -4.70 to -3.27). Significant differences between the obesity and control groups were observed in all subgroups except those using liquid chromatography-tandem mass spectrometry/mass spectrometry (LC-MS/MS) detection. Moreover, the prevalence of VD deficiency was higher in participants with obesity than in controls (odds ratio [OR], 2.02; 95% CI, 1.73 to 2.36). This difference was significant in all subgroups except those in which VD deficiency was defined as a concentration below 10 or 12 ng/mL. Furthermore, VD insufficiency was positively associated with the risk of obesity (OR, 1.17; 95% CI, 1.04 to 1.32). However, significant differences were observed only in specific subgroups: adolescents, participants with mild obesity, and those assessed using enzyme-linked immunosorbent assay or LC-MS/MS detection methods. Conclusion: These findings indicated that VD status was inversely associated with the risk of healthy obesity, irrespective of age and obesity grade. Inconsistencies may be influenced by VD detection methods and assessment criteria.
The authors' abstract, as published at the source. Journal of Obesity & Metabolic Syndrome, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pathology and Forensic Medicine
Pathology and Forensic MedicineMedicine